Filings & corporate actions
- 24 JuldividendDividend · ₹656.00 per share-2.4%
Reaction to results · all yearsrose on day 0 in 1 of 1 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q4 FY10 | 9 Jun 2010 | +1.6% | -0.6% | +7.2% | 0.7× |
| Average | +1.6% | -0.6% | +7.2% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Profit | — | — | — | — | — | — |
Key data
Delivery percentage
Over the last 20 sessions ABBOTINDIA settled 56.1% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 57.0%. The latest session ranks higher than 35% of the 3,629 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
Dividends, deals & holders
Performance returns
| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +3.23% | +0.32% | +4.59% | +1.55% | -4.29% | -9.59% |
Valuation
Ownership
Dividends
| Financial year | Payments | Declared | Adjusted |
|---|---|---|---|
| FY2026-27 | 1 | ₹656.00 | ₹656.00 |
| FY2025-26 | 1 | ₹475.00 | ₹475.00 |
| FY2024-25 | 1 | ₹410.00 | ₹410.00 |
| FY2023-24 | 1 | ₹325.00 | ₹325.00 |
| FY2022-23 | 1 | ₹275.00 | ₹275.00 |
| FY2021-22 | 1 | ₹275.00 | ₹275.00 |
| FY2020-21 | 1 | ₹250.00 | ₹250.00 |
| FY2019-20 | 1 | ₹65.00 | ₹65.00 |
| FY2018-19 | 1 | ₹55.00 | ₹55.00 |
| FY2017-18 | 1 | ₹40.00 | ₹40.00 |
| FY2016-17 | 1 | ₹35.00 | ₹35.00 |
| FY2015-16 | 1 | ₹31.00 | ₹31.00 |
| FY2014-15 | 1 | ₹23.00 | ₹23.00 |
| FY2013-14 | 1 | ₹17.00 | ₹17.00 |
| FY2012-13 | 1 | ₹17.00 | ₹17.00 |
| Ex-date | Record date | Declared | Adjusted |
|---|---|---|---|
| 24 Jul 2026 | — | ₹656.00 | ₹656.00 |
| 25 Jul 2025 | — | ₹475.00 | ₹475.00 |
| 19 Jul 2024 | — | ₹410.00 | ₹410.00 |
| 21 Jul 2023 | — | ₹325.00 | ₹325.00 |
| 2 Aug 2022 | — | ₹275.00 | ₹275.00 |
| 19 Jul 2021 | — | ₹275.00 | ₹275.00 |
| 28 Aug 2020 | — | ₹250.00 | ₹250.00 |
| 13 Aug 2019 | — | ₹65.00 | ₹65.00 |
| 10 Jul 2018 | — | ₹55.00 | ₹55.00 |
| 10 Jul 2017 | — | ₹40.00 | ₹40.00 |
| 8 Jul 2016 | — | ₹35.00 | ₹35.00 |
| 22 Jul 2015 | — | ₹31.00 | ₹31.00 |
| 23 Jul 2014 | — | ₹23.00 | ₹23.00 |
| 16 Apr 2013 | — | ₹17.00 | ₹17.00 |
| 4 May 2012 | — | ₹17.00 | ₹17.00 |
Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.
Bulk & block deals · 17 May 2011
CSV| Date | Deal | Client | Quantity | Price | Value |
|---|---|---|---|---|---|
| 17 May 2011 | Sell · bulk | ABBOTT CAPITAL INDIA LIMITED | 2.24L | 1,437.93 | ₹32.2Cr |
| 17 May 2011 | Buy · bulk | RELIANCE MUTUAL FUND (SCHEME : RELIANCE CAPITAL TRUSTEE CO. | 1.99L | 1,437.00 | ₹28.7Cr |
A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.
Takeover-code disclosures
Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.
Every stock on this session →Short selling, lending & margin
Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.
Exchange surveillance
No surveillance measure applies to ABBOTINDIA.
Price band: 20% · not in the F&O ban · 9.2% of the market-wide position limit used.
From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes · MWPL.
Every stock on this session →Futures & options · 27 Feb 2025
CSVLong unwinding — price down as positions closed — longs exiting.
- Futures OI
- 9.4K
- OI change
- -43.53%
- Basis
- -0.10%
- Rollover
- 0.0%
- PCR (OI)
- 0.96
- PCR (volume)
- 0.91
- Front settle
- 29,962.80
- Lot size
- 20
- Futures volume
- 1.3K
- Futures trades
- 1,230
- Futures value
- ₹79.7Cr
- Sessions shown
- 250
₹28.2Cr
shares
contracts
Open interest is in shares (index units for an index), summed over every expiry; volume, trades and traded value too. Settle and lot size are the front future’s. Buildup compares the close’s direction with the change in futures OI across the contracts still open, so an expiring contract does not read as unwinding. Scan it with pattern is long_buildup.
ABBOTINDIA at a glance
- ABBOTINDIA closed at ₹26,525 on 20 Nov 2026, +3.23% on the day, -9.6% over one year, 13.5% below its 52-week high of ₹30,655.
- Delivery was 52.3% of traded quantity on 20 Nov 2026, the 35th percentile of its own 3,629 sessions with a reading (20-session average 56.1%, 1-year average 57.0%).
- Market capitalisation is ₹56,364 crore, with no positive trailing earnings for a P/E.
About
Sector history
- to 16 Aug 2026Index industry · Healthcare
- from 16 Aug 2026Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
NSE’s own classification, by the snapshot it changed on.
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.
More in Pharmaceuticals & Biotechnology
- DIDIVISLABDivi's Laboratories Limited11,180.50+0.02%
- LALAURUSLABSLaurus Labs Limited2,294.60-0.49%
- SUSUNPHARMASun Pharmaceutical Industries Limited1,884.90-0.79%
- ACACUTAASAcutaas Chemicals Limited3,833.50-3.61%
- SASAILIFESai Life Sciences Limited1,800.70+0.69%
- PPPPLPHARMAPiramal Pharma Limited239.30-0.15%
- DRDRREDDYDr. Reddy's Laboratories Limited1,390.20-0.76%
- GLGLENMARKGlenmark Pharmaceuticals Limited2,648.00+1.51%
- AUAUROPHARMAAurobindo Pharma Limited1,799.00-0.37%
- CICIPLACipla Limited1,415.00-0.25%
- ZYZYDUSLIFEZydus Lifesciences Limited1,200.00-0.24%
- MAMANKINDMankind Pharma Limited2,665.00+1.37%
All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE